Will_Wong

LGND-A-B-C correction to wave {iv} nearing completion

Long
NASDAQ:LGND   Ligand Pharmaceuticals Incorporated
1
Entry point coming soon. With a recent earning report that surpassed estimates, LGND is expected to reach triple digit soon. A few analysts have upgraded LGND to a BUY with targets in the triple digits.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.